New Atlas January 23, 2024
The FDA has approved a wearable belt that delivers targeted vibrations to the spine and hips as the first non-drug prescription medical device to treat low bone density, the precursor to osteoporosis. Shown to be effective in clinical trials, the novel device offers postmenopausal women an alternative treatment to vitamin and mineral supplements.
Postmenopausal women are at high risk of fractures due to loss of the hormone estrogen. Because estrogen helps maintain bone density, this loss can lead to osteopenia or low bone density. The precursor to osteoporosis, osteopenia affects 40.4% of people globally.
Developed by Bone Health Technologies (BHT), Osteoboost is a novel wearable belt device that delivers vibrations to the lumbar spine and hips to...
Today's Sponsors
Today's Sponsor